Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design - Friedman, Scott; Sanyal, Arun; Goodman, Zachary; Lefebvre, Eric; Gottwald, Mildred; Fischer, Laurent; Ratziu, Vlad (Contemporary clinical trials, 2016)
Keywords: Administration, Oral; Adolescent; Adult; Aged; Cardiovascular; CCR5 Receptor Antagonists - therapeutic use; Cenicriviroc; Clinical Protocols; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Hematology, Oncology and Palliative Medicine; Humans; Imidazoles - therapeutic use; Liver Cirrhosis - complications; Liver fibrosis; Male; Metabolic syndrome; Middle Aged; Non-alcoholic fatty liver; Non-alcoholic Fatty Liver Disease - complications; Non-alcoholic Fatty Liver Disease - drug therapy; Non-alcoholic steatohepatitis; Prospective Studies; Research Design; Treatment Outcome; Type 2 diabetes mellitus; Young Adult; Non-alcoholic fatty liver; Liver fibrosis; Type 2 diabetes mellitus; Non-alcoholic steatohepatitis; Metabolic syndrome; Cenicriviroc; metabolic syndrome; type 2 diabetes mellitus; liver fibrosis; non-alcoholic fatty liver; non-alcoholic steatohepatitis